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1. INTRODUCTION 
There are several reasons why intracellular pro- 
tein catabolism is incompletely understood. The 
most quoted are the facts that protein catabolism 
involves multiple mechanisms and does not easily 
occur in the test tube, at least, to a readily 
manipulatable degree (cf. protein synthesis). 
However, a much more fundamental reason is that 
the multiple systems are intimately connected with 
all aspects of the life process. Degradation is the 
alternative for proteins during or immediately 
after synthesis, during secretion and after reaching 
their cytomorphological functional sites: in short, 
protein catabolism (including degradation after 
protein endocytosis) is primarily a cell biological 
phenomenon. Extracting the molecular detail of 
the multiple processes requires multiple biological 
approaches, providing a literature rich in a mixture 
of experimental models, designs and inter- 
pretations. 
In this review we want to consider critically the 
biological questions, the literature which addresses 
the questions and the current conundrums: the 
state of the art. We have taken the excellent 1982 
review of Hershko and Ciechanover [l] as 
representative of knowledge and understanding in 
1981 and have predominantly reviewed the 
literature from 1981 to 85. We have not considered 
degradative vents after endocytosis since they are 
adequately addressed elsewhere [2]. Those people 
interested in the views of many workers in the field 
would do well to read the summaries of presenta- 
tions at the Vth International Symposium on Pro- 
tein Catabolism [3]. 
Hershko’s analyses [l] saw intracellular protein 
catabolism as an extensive, selective set of 
energy(ATP)-requiring processes which have 
several functions including elimination of abnor- 
mal proteins and provision of amino acids in times 
of need. Non-lysosomal and lysosomal systems 
were identified which may act on ‘short’ and ‘long’ 
lived proteins respectively: the latter system being 
activated in a variety of cellular deprivation states. 
Finally and importantly, much of the earlier ex- 
perimentation was seen as phenomenological 
rather than molecular in nature. The analyses did 
not consider: (i) the question of cellular architec- 
ture, i.e. proteins function in defined sites and yet 
must interact with the catabolic systems; (ii) that 
proteins are really degraded with the rate of 
heterogeneity previously supposed; (iii) the ex- 
istence of ‘special’ systems, e.g. in heat shock or 
regulatory proteases responsive to calcium; (iv) 
degradation of proteins during secretion; (v) 
mitochondrial and chloroplast systems. 
We will consider intracellular protein catabolism 
from the point of view of (section 2) the systems: 
(section 2.1) the lysosomal system, (2.2) the 
secretory degradative system (defined as secretion- 
coupled degradation), (2.3) non-lysosomal 
systems, (2.4) ATP-dependent systems in pro- 
karyotes, eukaryotes and energy-transducing 
organelles, (2.5) calcium-dependent systems; and 
(section 3) the substrates: (3.1) how are the systems 
organised topographically with respect to 
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substrates, (3.2) how selective are the systems, 
(3.3) how much heterogeneity really exists, (3.4) 
what are the protein molecular features which 
determine sequestration into a system and 
degradative rate. 
2. THE SYSTEMS 
2.1. Lysosomes and degradation 
The basic question concerning these well- 
characterised organelles is the extent to which they 
participate in intracellular protein catabolism (cf. 
extra-lysosomal mechanisms) in each cell type. The 
studies have generally (but not exclusively) relied 
on inhibitors, which mostly incompletely inhibit 
lysosomal function and therefore may give 
somewhat problematical interpretation. However, 
initial studies [4-61 led to the so-called two- 
pathway hypothesis, which proposed that 
lysosomal and non-lysosomal systems could 
operate in each cell type. The extent of lysosomal 
involvement has been estimated to vary con- 
siderably depending upon cell type, growth 
characteristics of the cells and type of proteins 
studied [short-lived: radiolabelled for minutes 
(lo-30), or long-lived: radiolabelled for hours 
(16-48)]. 
Studies in perfused liver have shown a major 
lysosomal role in protein catabolism, in both the 
so-called basal (steady state with respect o protein 
synthesis) and enhanced (e.g. by nutritional 
deprivation) conditions [7,8]. Restoration of liver 
protein content on refeeding starved mice is ac- 
companied by an enormous (9Ocr/o) decrease in 
degradative rate presumed to be caused by de- 
creased autophagy [8]. A protein subgroup 
(16-18% of total) with a very short t1/2 (10 min) is 
unaffected by nutritional manipulation in liver [8]. 
Studies with isolated lysosomes from liver have 
suggested that both short- and long-lived proteins 
are degraded by lysosomes with approx. 20% of 
short-lived proteins (cf. [18]) subjected to extra- 
lysosomal (cytosol) degradation [9]. These studies 
with isolated lysosomes illustrate the incompletely 
inhibitory effect of lysosomotropic agents (which 
generally increase lysosomal pH) and proteolytic 
inhibitors (even in combination) on the lysosomal 
degradation of proteins. The results serve to em- 
phasise the fundamental problem of using in- 
completely effective inhibitors to study biological 
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processes. The design of these experiments does 
not permit identification of the so-called short- 
lived liver proteins although the secretion-coupled 
degradation (see below) of neosynthesised proteins 
by a crinophagic mechanism or extensive degrada- 
tion of neosynthesised membrane proteins [lo] 
may explain the observed large lysosomal con- 
tribution to the degradation of short-lived proteins 
[91. 
Long-lived proteins must have entered their 
cytomorphological functioning sites before 
degradation occurs. Lysosomal degradation of 
such proteins in liver cells is thought to occur by an 
autophagic process, i.e. cytoplasmic sequestration 
by an isolating membrane to form a closed vacuole 
(an autophagosome with a double membrane) 
followed by fusion with primary or secondary 
lysosomes (e.g. [ 111) to form autophagolysosomes. 
The initial autophagic process, i.e. formation of 
autophagosomes, can be inhibited by methylamino- 
purines [12,13], the most potent of which (3-meth- 
yladenine) inhibits hepatic autophagy by at least 
60% without affecting the degradation of ex- 
ogenous proteins [ 14,151. [‘4C]Sucrose (indigesti- 
ble in lysosomes) has been introduced into hepato- 
cytes by electropermeabilization [ 161 to measure 
the autophagic rate which is therefore completely 
inhibited by 3-methyladenine. Interestingly, an 
unexplained sequestration of [ 14C]sucrose by 
mitochondria occurs in this type of study which 
partially accounts for the overestimation of the 
autophagic rate by this approach. Even after cor- 
rection for this event the estimated autophagic se- 
questration rate is approximately double the 
autophagic degradation rate, perhaps reflecting 
recycling of sequestered cytoplasm or some selec- 
tivity in the process [17]. Clearly, compounds like 
3-methyladenine are of great value in distinguish- 
ing autophagic degradation from the degradation 
of proteins obligatorily inserted into intravesicular 
spaces during exocytosis (see below) and endo- 
cytosis. 
The degradation of liver proteins has been 
probed with several other inhibitory or disruptive 
compounds. Leupeptin, an inhibitor of many pro- 
teases, including cathepsins B, H and L [ 181, 
causes the initial appearance (30-60 min) of 
double-membraned autophagosomes and subse- 
quent (3-12 h) appearance of autophagolyso- 
somes in liver after injection into rats [19]. Several 
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cytosolic enzymes are continuously sequestered 
non-selectively into autophagolysosomes after 
leupeptin treatment [20]. Leupeptin causes a 
marked change in lysosomal density presumably 
by lysosomal constipation [ZO]. It has been sug- 
gested that leupeptin may offer a good model for 
elucidating mechanisms related to the formation of 
autophagic vacuoles in liver [21]. Certainly, 
hepatocytes in vitro tolerate prolonged exposure to 
leupeptin which can therefore be used to show con- 
vincingly that mitochondrial outer membrane 
transplanted into hepatocytes a~cumu1ates in peri- 
nuclear non-lysosomal non-mitochondrial struc- 
tures from which proteins are donated for 
degradation at precisely the same rates as from en- 
dogenous organelles in vivo, i.e. the proteins in 
these membranes preserve their degradation rates 
after deliberate miscompartmentalization [22,23]. 
The pharmacological disruption of cellular 
elements does not always lead to simple interpreta- 
tion. Disruption of hepatocytic microtubular 
elements by vinblastine causes interference with 
the autophagic system, probably by preventing 
autophagosome-lysosome fusion, so that in- 
tracellular protein degradation is impaired [24], 
but the degradation of proteins in isolated 
lysosome preparations is enhanced [25,26] possibly 
by in vitro autophagosome-lysosome fusion [24]. 
Although the functional interaction of elements of 
the cytoskefeton (microtubules, microfilaments 
and intermediate filaments) is complex (see below), 
there is no doubt that properly functioning 
microtubules are essential for protein degradation 
in liver parenchymal cells, not only for putative 
autophagosome-lysosome fusion [24] but also for 
membrane translocation to perinuclear sites before 
degradation of incumbent proteins occurs [22,23] 
and lysosomal translocation to pericanalicular sites 
in liver parenchymal cells after partial hepatec- 
tomy 1271. 
Low lysosomal pH, which is disrupted by 
lysosomotropic weak bases (e.g. [28]), is clearly 
essential for lysosomal function including protein 
degradation. Lysosomal pH is maintained by an 
ATP-driven acidification system [29] which is 
dependent on an ATP-driven electrogenic proton 
pump 130-321 and is disrupted by carboxyhc 
ionophores in hepatocytes with concomitant 
almost complete disruption of lysosomal protein 
degradation [33]. 
The predominantly 1ysosomaIly mediated pro- 
tein catabolism in hepatocytes must be contrasted 
with mechanisms operating in other cell types, 
specifically in growing and non-growing tissue 
culture cells. Microinjection and other studies in 
growing tissue culture cells show that autophagy 
accounts for little of the basal degradation of pro- 
teins whereas autophagy can account for most of 
the enhanced degradation in quiescent (non- 
growing) cells [34-391. 
Finally, the cytoskeletal dependence of the 
autophagi~-lysosomal system must again be em- 
phasised. Not only are microtubuies essential for 
the process as defined by microtubule-dissociating 
agents (see above) but also lysosomes are reported 
to be associated specifically with microtubules not 
intermediate filaments [40] as defined by im- 
muno~uorescence studies. Lysosomal membranes 
are also reported to possess integral membrane 
proteins which bind actin [41] and may be involved 
in saltatory lysosomal movements. 
After microinjection proteins can be segregated 
to become tightly associated with the vimentin-rich 
intermediate filament fraction in 3T3-L1 cells 1421 
before subsequent slow lysosomal degradation 
[36]. Although much work in recent years has iden- 
tified and quantitated the extent of lysosomally 
mediated autophagy in different cell types, it has 
not determined how proteins enter the lysosomal 
system other than to describe morphologically the 
exploitation of smooth endoplasmic reticulum 
membranes in the initial events (e.g. [21]). A key 
unresolved question concerns whether cytosolic 
and membrane proteins accumulate at some 
‘nucleation’ site (~ytoskeletally directed?) before 
the autophagic processing begins [42]. 
The importance of organisation in intraceIluIar 
space for normal protein degradation is well il- 
lustrated by studies of membrane transplantation 
122,231 and cytochalasin 3 enucleation (microfila- 
ment disruption) 143-451. In the latter, enucleation 
[46,47] or centrifugal steps used in enucleation [44] 
are sufficient to prevent the degradation of short- 
lived proteins [43,44] and short- and long-lived 
proteins [45]. Clearly, disruption of intracellular 
organisation and/or transcriptional events is essen- 
tial for protein catabolism. These events deserve 
much further study. 
183 
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2.2. Secretion-coupled egradation 
The degradation of secretory proteins en route 
from the Golgi apparatus to the cell surface is a 
well-established phenomenon [SO]. The phenome- 
non may be viewed in relation to precursor poly- 
peptide processing, whereby for example in a 
secretory granule precathepsin B may process pro- 
insulin and then itself be converted to cathepsin B 
during the later senescence of the insulin granule 
[51], presumably entering the general secondary 
lysosome compartment by vesicular fusion. Alter- 
natively, a prelysosomal vesicle (containing 
cathepsin D) may fuse with procollagen containing 
secretory granules before secretion [52]. The pro- 
portion of collagen degraded is conformation- 
dependent 153,541. Complete degradation may oc- 
cur in the endoplasmic reticulum [ 1,551 or between 
Golgi and the cell surface by lysosomotropic- 
sensitive pathways (561. The process is selective, 
partially degrading fibrinogen, but not transferrin 
during secretion in hepatocytes [57] and IgM ,u~ 
chains and not pm chains in Daudi cells [SS]. 
Predictably, glycosylation has a role in modulating 
degradation affecting lysosomal enzyme precur- 
sors and enzymes themselves in the endoplasmic 
reticulum and Iysosome, respectively 1551. In mam- 
mary lobulo alveolar cells secretion-coupled 
degradation [56] is transcriptionally and cell-shape 
related [59], being inversely related to secretory 
rate (Mayer, unpublished). Secretion-coupled 
degradation offers a major post-translational 
route of controlling net protein secretion as well as 
precursor processing. Clearly, alternative routes 
may exist for lysosomal enzyme precursors or en- 
zymes to enter secretory vesicles, e.g. direct 
packaging or vesicular fusion. Whatever the route, 
protein conjugate structure and dwell-time in the 
secretory labyrinth must determine the fate of the 
protein. 
2.3. Non-lysosomal degradation 
There are several aspects of this system which 
need consideration (see section 2.5) but direct 
evidence for the existence of non-lysosomal 
systems will be first evaluated (cf. indirect evidence 
for non-lysosomal systems based on lysosomo- 
tropic agents, see section 2.1). Microinjected ‘251- 
labelled bovine serum albumin has provided the 
most clear-cut evidence for a cytosolic degradation 
system since its degradation (ti,z approx, 20 h) is 
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largely unaffected by lysosomotropic agents 
[46,48], the majority of the degradation products 
of [t4C]sucrose-bovine serum albumin accumulate 
in the cytosol [47], its degradation rate is unaf- 
fected by serum withdrawal 1481 and the protein re- 
mains in the digitonin-extractable cytosolic frac- 
tion throughout the course of degradation [42]. 
Exhaustive methylation of the protein does not 
prevent non-lysosomal degradation in HTC cells 
[49]. Therefore one or more cytosolic degradation 
systems exist in eukaryotic cells. It is worth em- 
phasising here (see section 2.4) that prokaryotes 
obviously have no lysosomes and therefore must 
have extra-lysosomal degradative systems. In the 
course of evolution special adaptations of these 
systems may therefore be expected in eukaryotic 
cells. 
2.4. A TP-dependent extralysosome sytems 
2.4.1. Prokaryotic ATP-dependent protein 
systems 
Following the discovery that abnormal proteins 
of E. coli were degraded in an ATP-dependent 
fashion [60] a soluble ATP-dependent protease 
was identified and termed protease La (611. Mu- 
tant strains of E. coli known as lon (capR) mutants 
exhibit reduced proteolysis of nonsense 1621, 
missense [63] and normal proteins [64] and the 
purified lon gene product was found to be a pro- 
tease dependent on ATP hydrolysis [65]. Protease 
La and the Ion gene product were found to have 
the same sensitivity to inhibitors, identical 
molecular masses and La was absent from Ion- 
mutants suggesting that La and the lon gene 
product were the same protein [66]. 
Serine protease inhibitors were found to inhibit 
both proteolysis and ATP hydrolysis by La. The 
ATPase inhibitor vanadate also inhibited both ac- 
tivities suggesting that they occurred in a linked 
fashion [67]. Protein substrates stimulate ATP 
hydrolysis by La and proteolytic activity in the 
presence of ATP is stimulated by DNA 1681. 
Protease La has been implicated in the response 
of E. co/i to various stress situations including heat 
shock and is one of 17 known proteins produced 
during the heat shock response [69-711, which is 
controlled by the htpR-encoded protein, a sigma 
factor required for transcription of heat shock 
genes 1721. The effect of various inducers of the 
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heat shock response on the transcription of the lon 
gene has been studied using a lon-1acZ operon fu- 
sion gene where increased transcription led to in- 
creased fl-galactosidase activity. Amino acid 
analogues, puromycin and the presence in cells of 
multicopy plasmids carrying the gene for human 
plasminogen activator all served to increase lon 
transcription. Similarly, cells with decreased 
translational fidelity showed increased lon 
transcription [73]. It would seem therefore that the 
lon gene product-protease La is involved in the 
rapid degradation of abnormal proteins including 
cloned foreign gene products. 
Protease La is also involved in the response of E. 
cofi to ultraviolet irradiation. Len- mutants 
showed decreased ability to recover from 
ultraviolet irradiation as cells failed to divide. The 
sulA gene product is produced after irradiation 
and is thought to inhibit cell septation. When sulA 
is cloned into ion- mutants the half-life of the 
product is much longer (19 min) than in Ion+ cells 
(1.2 min) [74]. Thus, protease La may be involved 
in the regulation of important cell processes by 
controlling the concentration of critical proteins. 
A similar role for a protease-like activity has been 
seen with recA and the SOS response in E. coli (see 
[75] for a review). 
So far the ATP-dependent protease La has been 
implicated in the degradation of abnormal proteins 
in E. coli and its role, if any, in the degradation of 
normal proteins is not known. 
2.4.2. Eukaryotic ATP-dependent degradation 
The clearest example of non-lysosomal ATP- 
dependent proteolysis in eukaryotic systems has 
been found in the reticulocyte where the 
breakdown of endogenous protein was blocked 
when ATP synthesis was prevented [76]. This 
observation has led to extensive study of the ATP- 
dependent proteolytic system in the reticulocyte. 
A cell-free system from rabbit reticulocytes 
capable of ATP-dependent proteolysis was 
established [77] which was clearly soluble and non- 
lysosomal. Fractionation of reticulocyte lysate 
yielded two fractions (I and II) both of which were 
required for ATP-dependent proteolysis 178,791. 
The factor in fraction I required for proteolysis 
was found to be a heat-stable polypeptide of 9 kDa 
[78] and was subsequently found to be identical 
with ubiquitin, a polypeptide found in many 
species and tissues which can form conjugates with 
histone H2A [80]. Conjugation of ubiquitin with 
protein substrates is via the carboxyl glycine ([81]; 
for a review of this system up to 1983, see [82]) as 
with H2A and can lead to the formation of con- 
jugates with ubiquitin attached to more than one 
lysine [83] per substrate molecule and with poly- 
ubiquitins attached to the same lysine [84]. It had 
been thought that the t-amino group of lysine in 
substrate proteins is the site of ubiquitin attach- 
ment but recent work suggests that the N-terminal 
amino group will also accept ubiquitin and may in 
fact be necessary for maximum ubiquitin-mediated 
proteolysis [85]. Conjugates of ubiquitin and ‘251- 
labelled lysozyme are degraded by reticulocyte ex- 
tracts free of ubiquitin-conjugating activity in an 
ATP-dependent fashion whereas ‘251-labelled 
lysozyme is not, indicating that ubiquitin con- 
jugates are the substrates for this ATP-dependent 
mechanism and that both conjugate formation and 
degradation are ATP-dependent [86]. The con- 
jugation of ubiquitin to substrate proteins takes 
place via the formation of an adenylated ubiquitin 
catalysed by a ubiquitin-activating enzyme (El) 
and subsequently the formation of an El-ubiquitin 
thiol ester bond. The process results in the hydroly- 
sis of ATP [87,88]. The transfer of ubiquitin to 
substrate proteins is catalyzed by enzyme E3 which 
transfers the ubiquitin moiety from another inter- 
mediate (E2-S-Ub) [89]. A total of 5 E2 enzymes 
have been found so far with at least 4 being 
capable of transferring ubiquitin to small amines, 
H2A and cytochrome c in the absence of E3 [90]. 
The involvement of ubiquitin in a putative cycle 
for the degradation of proteins requires the 
regeneration of ubiquitin from the products of 
proteolysis of ubiquitin-protein conjugates. 
Recently, an enzyme that will cleave small amines 
- including lysine - from the carboxyl terminus of 
ubiquitin has been discovered which would serve 
this purpose [91]. Removal of ATP from incuba- 
tions of reticulocyte extracts containing ubiquitin- 
lysozyme conjugates prevents proteolysis of con- 
jugates and results in the release of free ubiquitin, 
suggesting the presence of an isopeptidase similar 
to that found in rat liver [92]. The presence of 
these activities permits the proposition of the 
scheme shown in fig.1. However, to date almost 
nothing is known about the reticulocyte enzyme(s) 
actually responsible for the degradation of 
ubiquitin-protein complexes. 
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lysine 
hydrolase 
Fig.1. Proposed ubiquitin (Ub)-mediated proteolysis in reticulocytes (adapted from [SZ]). 
An alternative explanation for the stimulatory 
effects of ATP and ubiquitin in proteolysis by 
reticulocyte extracts to the one described above has 
been put forward [93]. A proteolytic activity could 
be obtained from reticulocytes after removal of an 
ammonium sulphate precipitable fraction which 
exhibited rates of ATP-i~ldependent proteolysis 
similar to the complete system which includes both 
ATP and ubiquitin. Addition of the precipitated 
fraction led to an inhibition of proteolysis which 
was relieved by ATP and ubiquitin. It was sug- 
gested that reticuloc~es contain an inhibitor (am- 
monium sulphate precipitable) which is inactivated 
in the presence of ATP and ubiquitin. This could 
occur through the formation of ubiquitin-inhibitor 
conjugates or ubiquitin-substrate conjugates which 
prevent inhibitor binding [3]. 
The same workers found proteolytic activity in 
erythrocytes which is masked by an ATP- and 
ubiquitin-repressible labile inhibitor. 
2.4.2.1. Physiological role of the ubiquitin-ATP 
proteoIytic system. While a great deal has been 
learned about the ubiquitin-mediated proteolytic 
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system in reticulocytes, its physiological role re- 
mains unclear in both reticulocytes and other cells. 
Most investigators studying the system have 
employed exogenous protein substrates, e.g. 
bovine serum albumin (BSA), lysozyme, casein. 
However, it has been found that while BSA 
radioiodinated using chloramine-T is a good 
substrate for the reticulocyte system, enzymicaliy 
iodinated BSA is a poor substrate [94] suggesting 
that oxidative damage makes BSA more suscepti- 
ble to proteolysis by this system. However, the ef- 
fect of denaturation on the proteolysis of BSA by 
this system is not clear [95,96]. Reticulocytes in- 
cubated with amino-acid analogues show greater 
formation of protein-ubiquitin conjugates, sug- 
gesting that abnormally synthesized proteins may 
be more rapidly degraded by this system 1971. It is 
certainly the case that a large range of normal in- 
traceliular proteins are not readily degraded by the 
reticulocyte system [98]. 
The demonstration that the mitochondria con- 
taining stroma of reticulocytes is rapidly degraded 
by the reticulocyte-ubiquitin system has led some 
authors to propose that the system is involved in 
Volume 198, number 2 FEBS LETTERS March 1986 
the maturational loss of reticulocyte organelles 
[99]. In support of this it has been found that the 
ATP-dependent ubiquitin system is almost com- 
pletely lost in mature erythrocytes [1001. Similarly, 
the capacity of reticulocytes to degrade puromycin 
peptides and analogue-containing proteins is also 
lost [ 1081. Erythroid cells from donors with ,~3- 
thalassaemia showed rapid degradation of the ex- 
cess a-chains of haemoglobin which was ATP- 
dependent but it is not known if ubiquitin is in- 
volved [loll. It would seem therefore that several 
possibilities for a cell-specific role for the ubiquitin 
system in reticulocytes may exist. It must be em- 
phasised at this point that cyanogen bromide pep- 
tides are degraded in reticulocyte lysates by an 
ATP-independent system: these substrates may be 
the best model substrates to study this system 
[107]. 
the presence of an ATP-dependent non-IysosomaI 
proteolytic system in cultured cells but do not seem 
to show conclusively that ubiquitin is involved. 
2.4.2.2. Other cell types. If the ubiquitin-ATP 
system is concerned with reticulocyte-specific pro- 
cesses then it may not be active in other cell types. 
In fact it has proven difficult to demonstrate 
ubiquitin-mediated proteolysis in other cell types 
until recently. It appears that there exists in rabbit 
liver a ubiquitin-degrading activity and only when 
this is inhibited can ubiquitin-mediated proteolysis 
be demonstrated /102]. 
An alternative approach has been to develop cell 
mutants lacking ubiquitin-conjugating activity 
which fail to conjugate ubiquitin to histone HZA 
[ 1051. These cells are unable to degrade proteins 
that have been labelled with radioactive 
methionine for very short times, i.e. newly syn- 
thesized proteins, in both the presence and absence 
of amino-acid analogues [106]. No data were 
shown for any effect on the turnover of proteins 
labelled for Ionger periods. It may be that the 
system is active only on newly synthesized proteins 
which are in fact subject to extensive rapid 
hydrolysis [ 116,167]. Interestingly, it has been 
shown that protein turnover in both reticulocyte 
lysates and CHO cells is sensitive to the level of 
charged tRNA which suggests a link between the 
protein-synthesizing machinery of the cell and 
ubiquitin-mediated proteolysis [ 168,169]. Finally, 
it has been noted that heat shock induces the syn- 
thesis of ubiquitin mRNA in chick fibroblasts, 
which may serve to allow the degradation of in- 
creased amounts of abnormal protein [170]. 
2.4.3. Energy-transducing organelles 
In an attempt to demonstrate ubiquitin pro- ATP-dependent proteolytic systems have been 
teolysis in intact cells microinjection techniques demonstrated in both mitochondria [ 1 lo- 1131 and 
have been employed. ‘251-labelIed ubiquitin when chloroplasts [ 114- 1161. In mitochondria an ATP- 
microinjected into HeLa cells was found to con- dependent matrix enzyme may be essential for en- 
jugate mainly with histone H2A and few other pro- suring the balance between products of nuclear 
teins f103j. Treatment of erythrocytes, into which and mitochondrial genomes [I 13,117) by 
‘z51-labelled ubiquitin had been loaded with degrading excess polypeptides. The role of the 
phenylhydrazine to denature the haemoglobin, led ATP-dependent enzyme on the outside of the inner 
to much greater conjugate formation in recipient mitochondrial membrane is Iess clear [ 1 IO,1 1 11. In 
cells 11041. However, this does not tell us if ubi- chloroplasts proteolytic systems degrade the im- 
quitin conjugates are formed with recipient cell ported small subunit of ribulose-1 ,%bisphosphate 
proteins. Microinjection has also been employed to carboxylase [114] when the large subunit is 
introduce labelled substrate proteins into culture depleted. Newly synthesised proteins are degraded 
cells. BSA and lysozyme were degraded rapidly by an ATP-dependent proteolytic system [116]. 
after microinjection into HeLa cells in a lysosome- Chloroplast degradation is also light-sensitive and 
independent and ATP-dependent fashion [49]. can be coupled to electron transport rather than 
However, when the substrates were exhaustively phosphorylation [1151. Although a proteolytic role 
methylated to block free amino groups the in controlling assembly of products of the two 
degradation of the proteins was unaltered after genomes is important and attractive, there is as yet 
microinjection but was drastically reduced when no real substance for understanding the degrada- 
these proteins were exposed to the reticulocyte tion of individual proteins in these supramacro- 
system. These experiments seem to demonstrate molecular structures (see section 3). 
187 
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2.5. Calcium-dependent proteolytic systems 
Calcium-dependent proteases and their in- 
hibitors have been discovered in a variety of cell 
types [ 118-1231. The calcium sensitivity of many 
acute intracellular regulatory processes may sug- 
gest regulatory roles for calcium-dependent pro- 
teases. The currently most intriguing systems are 
proposed to relate to the cytoskeleton. A calcium- 
activated neutral protease was isolated from 
Ehrlich cells with a high but limited proteolytic ac- 
tivity for the N-termini of vimentin, desmin and a 
60 kDa cytokeratin [124,125]. The protease was 
found to be ubiquitous in nature and its action 
prevents formation of intermediate filaments 
[ 1251. It was originally proposed that the calcium- 
activated protease was involved in vimentin 
turnover [124] but intriguingly vimentin may turn 
over very slowly, if at all, in Ehrlich cells [126]. In 
astrocytes, filaments containing vimentin and glial 
fibrillary acidic protein are degraded into 
fragments by a calcium-dependent proteolytic 
system giving rise to some detergent-soluble 
fragments as well as insoluble aggregates [125,127] 
which may be disulphide-linked. Several related 
calcium-dependent proteases can be purified from 
brain which may mediate cytoskeletal protein 
breakdown [128]. Neurofilament breakdown into 
detergent-insoluble fragments can be mediated by 
the calcium-dependent protease [ 1291. The occur- 
rence of aggregates [12.5,127,128] after partial 
degradation of cytoskeletal elements may be im- 
portant for cataract development in lens, which 
contains a vimentin-specific alcium-activated pro- 
tease as well as high-molecular-mass aggregates 
containing crystallins, actin and vimentin [ 1301. 
From a putative regulatory viewpoint it is 
fascinating that calcium-activated proteases purify 
with associated CAMP-dependent and -indepen- 
dent protein kinases which may involve interac- 
tions with inhibitors of the proteases [1311. 
These fascinating studies need to be accom- 
panied by definitive proof that intracellular 
cytoskeletal fragmentation is dependent on 
calcium-activated proteases. However, in view of 
the tight association of some microinjected pro- 
teins with the vimentin intermediate filaments of 
fibroblasts [42] before lysosomal degradation, it is 
likely that intermediate filaments in each cell type 
might act as nucleation sites for proteins destined 
to be degraded lysosomally after partial calcium- 
188 
dependent filament fragmentation and aggre- 
gation. 
The binding of haemoglobin to the cytosolic 
face of the erythrocyte membrane (membrane 
cytoskeleton related?) appears necessary for pro- 
calpain activation and regulated degradation [1091. 
Finally, a word on calcium and muscle. 
Preliminary results suggested that calcium- 
stimulated muscle protein catabolism may involve 
prostaglandins and be mediated lysosomally 
[ 132,133]. However, recently [134] it has been 
shown that non-lysosomal leupeptin and 
E-64-sensitive proteases are responsible for 
calcium-dependent proteolysis in muscle. Since 
calcium may also control autophagy in hepatocytes 
[135] much further work needs to be carried out to 
clarify the role of calcium in these processes. 
3. THE SUBSTRATES 
3.1. Proteins in functional topographic sites 
Intracellular protein catabolism obviously needs 
not only the systems but also the substrates. Full 
understanding of protein catabolism in eukaryotic 
cells means that the routing of individual proteins 
from functional sites to degradative sites will need 
to be understood. Attention must be paid in all 
models to the fact that proteins function in sites as 
diverse as nucleus and plasma membrane and yet 
must gain access to the proteolytic systems. Non- 
selective autophagy will not suffice for nuclear 
protein catabolism or differential turnover of 
plasma membrane receptors and membrane 
cytoskeleton. This concept is enshrined in the view 
of a protein turnover cycle in eukaryotic cells 
whereby proteins not only enter their functioning 
sites during organelle biogenesis but exit for the 
retrograde destructive arm of the cycle [136]. Im- 
pedance of either the orthrograde or retrograde 
arms of such a cycle would result in cellular inclu- 
sions (see section 2.5) including, e.g. 
neurofibrillary tangles in Alzheimer’s disease, 
which could occur in specific neurones with con- 
comitant memory malfunction [ 1371. 
Equally important for the overall view is 
recognition that intracellular proteins function in 
topographic sites equivalent o the cytosolic space 
and lysosomal lumen, e.g. in secretion-coupled 
degradation. It is clear that proteins in lysosomal 
lumenal equivalents are lumenally degraded 
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whereas proteins enjoying cytosolic topographical 
location may be degraded cytosolically [42,46-481 
or lysosomally (34-36,42,46-481. The latter route 
begs the unresolved question of how proteins gain 
access to the lysosomal lumen, e.g. by a 
microautophagic route [ 1381. 
3 2. Selectivity and heterogeneity 
Attitudes to the topographical question rely on 
an appreciation of not only the number of 
degradative systems (see section 2) but also the 
selectivity of the systems which determines the 
heterogeneity of degradation rates. Current opin- 
ion would agree that proteins with extremely fast 
degradation (tl/z =c 15 min) (e.g. (81) exist (related 
to the infidelity and abnormality of protein syn- 
thesis) and proteins, often regulatory enzymes, 
with fast degradation rates (e.g. [140-1421) clearly 
exist. The degree of heterogeneity of degradation 
of all other intracellular proteins may logically 
necessitate the determination of rates for 
50-100000 proteins per cell. In earlier reviews 
[143-1451 published degradation rates, often 
determined by imprecise methodology, were 
quoted as supporting a total heterogeneity of 
degradation rates. However, two-dimensional 
isoelectric focussing - SDS-polyacrylamide gel 
electrophoretic analyses of proteins in liver 
mitochondrial subcompartments [ 1461 and mam- 
mary cytosol [147] - indicate that proteins in 
biosynthetically defined cytomorphological sites 
are degraded in small numbers of families or 
populations (e.g. ~4) where the rates in each 
population are similar if not identical. This view is 
supported by rate frequency analysis of degrada- 
tion rates of proteins in hepatoma plasma mem- 
brane [ 1481 and mitochondria [149,150]. It is also 
supported by the fact that proteins in transplanted 
mitochondrial outer membrane are degraded at 
strict alternative rates in a variety of tissue culture 
cells [139,151] and not with a great heterogeneity 
of rates. Therefore, a strictly limited degree of 
heterogeneity of degradation rates may be found in 
each cell type for long-lived proteins, simplifying 
the currently incompletely understood problem of 
selectivity considerably. 
3 -3. Protein structure and degradation 
A preoccupation of researchers in the late sixties 
and seventies was to establish the so-called correla- 
tions between protein structure and degradation 
rate. These correlations purported to show that 
proteins were degraded faster because they were 
larger, more acidic or more hydrophobic. These 
correlations were claimed for proteins in many 
subcellular compartments, including the cytosol 
[152-l 571. Correlation of such general physi- 
cochemical properties with specific individual 
degradation rates seems inherently unlikely. Subse- 
quently, many reports contradicted the correla- 
tions for all subcellular fractions [ 147,148,l S8- 
1611 and also refuted protein unfolding or de- 
naturation as indicators of degradation rate 
[162,163]. Indeed, microinjection studies have 
shown that removal of a short (20 amino acid) N- 
terminal portion from a protein can prevent 
lysosomal degradation on serum withdrawal [35]. 
Furthermore, the specificity of the sensitive sterol 
control of HMG-CoA reductase degradation in en- 
doplasmic reticulum [140] is abolished with the N- 
terminal truncated product of a truncated 
transfected reductase gene [ 141,142], again show- 
ing the exquisite nature of the signal sequences for 
protein degradation. Finally, in a recent report on 
(Y- and fl-spectrin precursor degradation it was 
noticed that gross physical criteria are too general 
to account for the high degree of specificity 
displayed by two proteolytic mechanisms 
(lysosomal and non-lysosomal) which distinguish 
these two closely related precursor polypeptides 
[164]. 
Protein modification as a signal for degradation 
(cf. the ubiquitin system) has been a recurring con- 
cept in trying to unravel the intricacies of protein 
degradation. A popular hypothesis involves ox- 
idative modification [165] or conjugation with 
biological disulphides [166]. Perhaps readers of 
this review will feel that the earlier correlations 
should be laid to rest so that the elegant new 
cellular and molecular biological techniques 
[22,142,143] can be used to resolve the 
macromolecular ecognition features which deter- 
mine degradation rate. 
4. THE CURRENT STATE OF THE ART 
Fig.2 attempts to rationalize available data for 
eukaryotes as a protein turnover cycle [136] in 
which both the synthesis and degradation of pro- 
teins can be accommodated. The orthograde arm 
189 
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Fig.2. Protein turnover cycle. X, newly synthesized 
protein; A, protein functional site; C, cytosol; B, 
sequestration site for autophagic pathway. 
of the cycle involves translocation of proteins 
either to functional organellar sites (A) or cytosolic 
spaces (C) from a pool of newly synthesized pro- 
teins (X). The retrograde processes are multiple 
with newly synthesized proteins (including abnor- 
mal proteins) produced on free polysomes subject 
to a degree of rapid ATP-dependent (ubiquitin?) 
degradation and those produced on membrane- 
bound polysomes subject to topographically 
distinct rapid lumnal (endoplasmic reticulum or 
lysosomal) degradation. Proteins may leave their 
functional sites (A), e.g. the nucleus (Fernig and 
Mayer, unpublished), for degradation by cytosolic 
or lysosomal mechanisms at much slower rates. 
Transfer to lysosomes involves collection at some 
site (B) for donation into the autophagic system. In 
prokaryotes and energy-transducing organelles the 
amino acid-X, X-+C, C+amino acids steps are 
presumably operative. Each mechanism may well 
be ATP-dependent . The model cannot be exclusive 
and new data from the many biological approaches 
reviewed here will determine if it stands the test of 
time. 
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